law360.com
Thermo Fisher Scientific Inc. said Wednesday it will acquire Clario Holdings Inc., a provider of endpoint data solutions for clinical trials, from a shareholder group led by Astorg and Nordic Capital, Novo Holdings and Cinven, for $8.875 billion in cash.
about 1 month ago